Longitudinal Evaluation of Antibody Kinetics of Vaccinated Patients With Non-mandatory Vaccine Following Administration of a Non-public Marketed Vaccine in the General Population, Real-life Study

Launched by CERBAXPERT · Apr 15, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how the body responds to a non-publicly available vaccine over time, particularly focusing on the levels of antibodies—proteins that help fight infections—after vaccination. Researchers want to understand how these antibody levels change in different groups of people based on factors like age and gender. This information can help determine if some individuals might need booster doses of the vaccine and assess the overall impact of this vaccine on public health.

To participate in this study, you need to be at least 18 years old and have either been vaccinated or plan to get vaccinated. You should also be able to understand the study's purpose and give your consent to participate. Participants will visit a research center as part of their usual healthcare, and the information gathered will help improve vaccine policies in the future. It's important to note that individuals under legal protection or guardianship cannot participate in this trial.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Subject over 18 years of age
• • Subject presenting to the investigation centre as part of its usual management (prevention, screening, tracking)
• • Subject who has been vaccinated and/or wishes to be vaccinated
• • Subject able to understand the purpose of research that has given free and informed express consent
• • Member or beneficiary of a social security scheme
• Exclusion Criteria:
• • Protected subject: major under guardianship, curatorship or other legal protection, deprived of liberty by decision judicial or administrative